Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04320732

Risk Factors for Community- and Workplace Transmission of COVID-19

The project is an epidemiological observational study based on an electronic questionnaire on risk factors for COVID-19 in the community and healthcare setting.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Coronavirus Coronaviridae Infections Coronavirus Infections Infections Nidovirales Infections RNA Virus Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Summary The data collected will identify real-life risk factors for getting the COVID-19 diagnosis.

The Oslo University Hospital/University of Oslo web-based solution "nettskjema" will be used to collect data and consent forms.

The impact of knowing the risk factors for COVID-19 is tremendous because it can enable governments to conduct more targeted public health measurements than today to reduce the spread of the virus.

Detailed description Research into an ongoing COVID-19 outbreak is difficult because patients are isolated, and supplies of personal protective equipment (PPE) supplies are limited. The risk of transmission to study personal is non-negligible even when PPE is available.

A study design based on an electronic questionnaire and consent from delivered from the Oslo University Hospital/University of Oslo, GDPR (General Data Protection Regulation) compliant "TSD" service has therefore been chosen.

The study will be a case-control study based on a combined electronic consent form and questionnaire that the participants will fill in using a smartphone and electronic identification.

The groups that will be included are:

  • Hospitalized and non-hospitalized patients/persons with COVID-19 at all stages of the disease and after the disease
  • Hospitalized patients without COVID-19
  • Healthcare personal or other groups with an increased risk of COVID-19
  • Healthy volunteers

Participants may be followed with repeated questionnaires prospectively.

Biological samples Biological samples may hold crucial information about the susceptibility to COVID-19 and for susceptibility to the progression of the disease. It is within the scope of the study to analyze such samples from a limited number of participants which will be asked to provide such samples or hospitalized patients that have surplus material. The material will be analyzed with non-genetic methods most suitable to provide such information.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Norwegian adult

Exclusion criteria

  • Unable to consent

Treatment and study plan

Observation of behavior and COVID-19 infection will be conducted.

Behavioral

No intervention, only prospective observation of behavior will be conducted by a questionnaire.

Primary outcomes

  1. Rate of COVID-19 infection

    Time frame: 1 year

    Diagnosed with serology or direct viral detection

Study contacts

Contact information is provided by the study sponsor or research team.

Arne Søraas, MD, PhD

CONTACT

[email protected]

+4790652904

John Arne Dahl, PhD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Collaborators

  • Age Labs AS

Registry information

Important dates

Study start
2020
Primary completion
2025
Study completion
2030
First posted
Mar 25, 2020
Registry last updated
Dec 13, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.